KAS
CTSO icon

Kestra Advisory Services’s Cytosorbents Corp CTSO Stock Holding History

Kestra Advisory Services’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5K Hold
28,200
– – ﹤0.01% 3247
2026
Q1 		$16K Buy
28,200
+2,500
+10% +$1.71K ﹤0.01% 3096
2025
Q4 		$16.4K Sell
25,700
-38,828
-60% -$29.9K ﹤0.01% 4526
2025
Q3 		$60.3K Sell
64,528
-6,352
-9% -$6.26K ﹤0.01% 2850
2025
Q2 		$90.7K Hold
70,880
– – ﹤0.01% 2743
2025
Q1 		$70.9K Buy
70,880
+15,880
+29% +$16.7K ﹤0.01% 2624
2024
Q4 		$50K Buy
55,000
+41,800
+317% +$41K ﹤0.01% 2608
2024
Q3 		$19.8K Buy
+13,200
New +$14.5K ﹤0.01% 2529

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Kestra Advisory Services's CTSO Position: Q2 2026 in Review

Kestra Advisory Services held its Cytosorbents Corp (CTSO) position steady in Q2 2026 at 28,200 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3247.

Kestra Advisory Services first reported a position in CTSO in Q3 2024 and has held it in 8 quarters since. The position peaked at $90.7K in Q2 2025. 42 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • Kestra Advisory Services held 28,200 shares of Cytosorbents Corp worth $10.5K as of Q2 2026.
  • Kestra Advisory Services left its Cytosorbents Corp share count unchanged in Q2 2026.
  • Cytosorbents Corp made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #3247 holding.
  • Kestra Advisory Services first reported a position in Cytosorbents Corp in Q3 2024 and has held it in 8 quarters since.
  • Kestra Advisory Services's Cytosorbents Corp position peaked at $90.7K in Q2 2025.
  • 42 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.